Skip to main content

Table 1 Basic descriptive characteristics of patients

From: Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

Characteristic

Number (percentage) of patientsa

Gender

 

   Males

14 (54%)

   Females

12 (46%)

Diagnosis

 

   Acute lymphoblastic leukemia

4 (17%)

   Acute myeloid leukemia

7 (29%)

   Myeloproliferative syndrome

5 (17%)

   Chronic lymphatic leukemia

2 (8%)

   Chronic myeloid leukemia

1 (4%)

   Myelodysplastic syndrome

4 (13%)

   Non-Hodgkin lymphoma

2 (8%)

   Hodgkin disease

1 (4%)

Age at ATG treatment, years

 

   Mean (minimum, maximum)

43 (24, 62)

Number of ATG doses

 

   Two

11 (42%)

   Three

12 (46%)

   Four

3 (12%)

Post-ATG body temperature

 

   Normal body temperature

20 (77%)

   Body temperature <37.5°C

5 (20%)

   Body temperature >37.5°C

1 (3%)

  1. aValues are presented as number (percentage) of patients, except for those of 'Age at ATG treatment', which are presented as mean (minimum, maximum). ATG, anti-thymocyte globulin.